Your browser doesn't support javascript.
loading
The McCAVE Trial: Vanucizumab plus mFOLFOX-6 Versus Bevacizumab plus mFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC).
Bendell, Johanna C; Sauri, Tamara; Gracián, Antonio Cubillo; Alvarez, Rafael; López-López, Carlos; García-Alfonso, Pilar; Hussein, Maen; Miron, Maria-Luisa Limon; Cervantes, Andrés; Montagut, Clara; Vivas, Cristina Santos; Bessudo, Alberto; Plezia, Patricia; Moons, Veerle; Andel, Johannes; Bennouna, Jaafar; van der Westhuizen, Andre; Samuel, Leslie; Rossomanno, Simona; Boetsch, Christophe; Lahr, Angelika; Franjkovic, Izolda; Heil, Florian; Lechner, Katharina; Krieter, Oliver; Hurwitz, Herbert.
  • Bendell JC; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, Tennessee, USA.
  • Sauri T; Vall d'Hebron University Hospital, Barcelona, Spain.
  • Gracián AC; Centro Integral Oncológico Clara Campal, Hospital Madrid Norte Sanchinarro, Madrid, Spain.
  • Alvarez R; Centro Integral Oncológico Clara Campal, Hospital Madrid Norte Sanchinarro, Madrid, Spain.
  • López-López C; Marqués de Valdecilla University Hospital, Santander, Spain.
  • García-Alfonso P; Hospital Universitario Gregorio Maranon, Madrid, Spain.
  • Hussein M; Florida Cancer Specialists, Leesburg, Florida, USA.
  • Miron ML; Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Cervantes A; Department of Medical Oncology, Biomedical Research Institute, INCLIVA, University of Valencia, Valencia, Spain.
  • Montagut C; Hospital del Mar, Barcelona, Spain.
  • Vivas CS; Institut Català d'Oncologia and L'Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.
  • Bessudo A; California Cancer Associates for Research and Excellence, San Diego, California, USA.
  • Plezia P; Arizona Clinical Research Center, Tucson, Arizona, USA.
  • Moons V; Imelda General Hospital, Bonheiden, Belgium.
  • Andel J; County Hospital Steyr, Steyr, Austria.
  • Bennouna J; Institut de Cancerologie de l'Ouest, Saint Herblain, France.
  • van der Westhuizen A; Calvary Mater Hospital, Newcastle, Australia.
  • Samuel L; Aberdeen Royal Infirmary, University of Aberdeen, Aberdeen, United Kingdom.
  • Rossomanno S; Roche Innovation Center Basel, Basel, Switzerland.
  • Boetsch C; Roche Innovation Center Basel, Basel, Switzerland.
  • Lahr A; Roche Innovation Center Munich, Penzberg, Germany.
  • Franjkovic I; Roche Innovation Center Munich, Penzberg, Germany.
  • Heil F; Roche Innovation Center Munich, Penzberg, Germany.
  • Lechner K; Roche Innovation Center Munich, Penzberg, Germany.
  • Krieter O; Roche Innovation Center Munich, Penzberg, Germany.
  • Hurwitz H; Duke University Medical Center, Durham, North Carolina, USA.
Oncologist ; 25(3): e451-e459, 2020 03.
Article en En | MEDLINE | ID: mdl-32162804
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Compuestos Organoplatinos / Neoplasias Colorrectales Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Compuestos Organoplatinos / Neoplasias Colorrectales Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article